Skip to main content
Ciulli Laboratory
School of Life Sciences, University of Dundee
Main menu
Home
Alessio Ciulli
Research
Group
Publications
Positions
News
Contact
Home
Alessio Ciulli
Research
Targeted Protein Degradation: PROTACs
Cullin RING E3 Ubiquitin Ligases
Chromatin-Reader Domains
Fragment-Based Ligand Discovery
Chemical Probes
Group
Past Group Members
Past Group Photos
Ciulli Lab Cards
Group Achievements
Publications
Journal Club
Positions
Postdoctoral Scientists
Postgraduate Studentships
Visiting PhD Students
Summer studentships / Internships
News
Contact
News
September 2022
Amphista therapeutics opens Cambridge's Granta Park research facility and is named “Fierce 15” Biotech Companies of 2022
August 2022
Research breakthrough will help develop future treatments against Parkinson’s disease
Now published in Chemical Society Reviews: Claudia & Alessio's review on VHL ligands and their use as VHL inhibitors and in PROTAC degraders
July 2022
Tag tech collaboration to battle undruggable diseases
SULSA funding success for early career researchers
May 2022
Drug Discovery Award for Alessio Ciulli
Amphista announces collaborations potentially worth $2 billion
Marie Skłodowska-Curie Fellowship Success for Xingui Liu
April 2022
Alessio talks to Sofia Rodriguez on Beacon Brainstorm on Drug Design and the Future of TPD
March 2022
Newly published in Annual Reviews of Biochemistry: Angus & Alessio's review on E3 Ligase Substrate Specificity for Targeted Protein Degradation
Pages
« first
‹ prev
1
2
3
4
5
6
7
8
9
…
next ›
last »
